<DOC>
	<DOCNO>NCT01789047</DOCNO>
	<brief_summary>The study involve eighteen-week , double-blind , placebo-controlled parallel design comparison add-on topiramate add-on placebo stable treatment amatadine treatment PD patient continue dyskinesia amantadine .</brief_summary>
	<brief_title>Topiramate Adjunct Amantadine Treatment Dyskinesia Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Dyskinesia , Drug-Induced</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>1 . Parkinson 's disease patient , define UK Brain Bank criteria 2 . Current age 3090 3 . Clinically pertinent dyskinesia define CGIs score ( see attachment ) &gt; 3 ( mild ) establish clinician 's total assessment patient include objective observation screen process . * 4 . Stable dos antiparkinsonian medication least 4 week 5 . Stable treatment least 200 mg amantadine least 4 week . 6 . Presence caregiver willing participate study 7 . In opinion enrol investigator , subject able maintain current dosing schedule antiparkinsonian drug duration trial . 8 . Subjects must free dementia , depression psychosis determine clinical examination . 9 . The subject must willing participate study related activity visit . Exclusion criterion : 1 . Any subject clinical evidence suggestive atypical secondary form Parkinson 's Disease 2 . Any subject , opinion Principal Investigator , concomitant medical illness would preclude treated amantadine , 3 . Any subject , opinion Principal Investigator , unable maintain current stable dosing antiparkinsonian medication duration trial , 4 . Any subject evidence dementia , depression , psychosis , determine clinical examination . 5 . Any subject sign informed consent , unable unwilling participate study related activity .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>dyskinesia</keyword>
	<keyword>Indonesia</keyword>
	<keyword>amantadine</keyword>
</DOC>